128 related articles for article (PubMed ID: 18855201)
1. Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulphate.
Alhusban FA; Seville PC
J Microencapsul; 2009 Aug; 26(5):444-55. PubMed ID: 18855201
[TBL] [Abstract][Full Text] [Related]
2. Sustained delivery by leucine-modified chitosan spray-dried respirable powders.
Learoyd TP; Burrows JL; French E; Seville PC
Int J Pharm; 2009 May; 372(1-2):97-104. PubMed ID: 19429272
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate.
Learoyd TP; Burrows JL; French E; Seville PC
Eur J Pharm Biopharm; 2008 Feb; 68(2):224-34. PubMed ID: 17560772
[TBL] [Abstract][Full Text] [Related]
4. Sustained delivery of salbutamol and beclometasone from spray-dried double emulsions.
Learoyd TP; Burrows JL; French E; Seville PC
J Microencapsul; 2010; 27(2):162-70. PubMed ID: 19538030
[TBL] [Abstract][Full Text] [Related]
5. The influence of formulation components on the aerosolisation properties of spray-dried powders.
Rabbani NR; Seville PC
J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
[TBL] [Abstract][Full Text] [Related]
6. Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders.
Raula J; Lähde A; Kauppinen EI
Int J Pharm; 2009 Jan; 365(1-2):18-25. PubMed ID: 18789380
[TBL] [Abstract][Full Text] [Related]
7. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
8. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
You Y; Zhao M; Liu G; Tang X
J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
[TBL] [Abstract][Full Text] [Related]
9. Investigations on particle surface characteristics vs. dispersion behaviour of L-leucine coated carrier-free inhalable powders.
Raula J; Thielmann F; Naderi M; Lehto VP; Kauppinen EI
Int J Pharm; 2010 Jan; 385(1-2):79-85. PubMed ID: 19879344
[TBL] [Abstract][Full Text] [Related]
10. Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate.
Raula J; Rahikkala A; Halkola T; Pessi J; Peltonen L; Hirvonen J; Järvinen K; Laaksonen T; Kauppinen EI
Int J Pharm; 2013 Jan; 441(1-2):248-54. PubMed ID: 23200957
[TBL] [Abstract][Full Text] [Related]
11. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
Dhumal RS; Biradar SV; Paradkar AR; York P
Int J Pharm; 2009 Feb; 368(1-2):129-37. PubMed ID: 18996462
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
Pilcer G; Vanderbist F; Amighi K
Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
[TBL] [Abstract][Full Text] [Related]
15. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
Thi TH; Danède F; Descamps M; Flament MP
Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
[TBL] [Abstract][Full Text] [Related]
16. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
Sansone F; Aquino RP; Del Gaudio P; Colombo P; Russo P
Eur J Pharm Biopharm; 2009 May; 72(1):206-13. PubMed ID: 18996478
[TBL] [Abstract][Full Text] [Related]
17. Development of inhalable dry powder formulation of basic fibroblast growth factor.
Ibrahim BM; Jun SW; Lee MY; Kang SH; Yeo Y
Int J Pharm; 2010 Jan; 385(1-2):66-72. PubMed ID: 19853028
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
Eedara BB; Tucker IG; Das SC
Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294
[TBL] [Abstract][Full Text] [Related]
19. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
Minne A; Boireau H; Horta MJ; Vanbever R
Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
[TBL] [Abstract][Full Text] [Related]
20. Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation.
Li L; Leung SSY; Gengenbach T; Yu J; Gao GF; Tang P; Zhou QT; Chan HK
Int J Pharm; 2017 Sep; 530(1-2):30-39. PubMed ID: 28709940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
